Atara Biotherapeutics Statistics
Total Valuation
ATRA has a market cap or net worth of $85.97 million. The enterprise value is $82.02 million.
Important Dates
The last earnings date was Monday, August 11, 2025, after market close.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ATRA has 7.02 million shares outstanding. The number of shares has increased by 103.16% in one year.
| Current Share Class | 7.02M |
| Shares Outstanding | 7.02M |
| Shares Change (YoY) | +103.16% |
| Shares Change (QoQ) | +13.45% |
| Owned by Insiders (%) | 2.58% |
| Owned by Institutions (%) | 28.44% |
| Float | 4.42M |
Valuation Ratios
The trailing PE ratio is 21.73 and the forward PE ratio is 19.74.
| PE Ratio | 21.73 |
| Forward PE | 19.74 |
| PS Ratio | 0.67 |
| Forward PS | 1.87 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 14.15 |
| EV / Sales | 0.43 |
| EV / EBITDA | 3.42 |
| EV / EBIT | 4.23 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.70
| Current Ratio | 1.70 |
| Quick Ratio | 1.53 |
| Debt / Equity | n/a |
| Debt / EBITDA | 0.48 |
| Debt / FCF | n/a |
| Interest Coverage | 4.63 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 15.71% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 86.73% |
| Revenue Per Employee | $1.23M |
| Profits Per Employee | $37,876 |
| Employee Count | 153 |
| Asset Turnover | 2.45 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -33,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +73.81% in the last 52 weeks. The beta is 0.26, so ATRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | +73.81% |
| 50-Day Moving Average | 10.21 |
| 200-Day Moving Average | 9.29 |
| Relative Strength Index (RSI) | 60.80 |
| Average Volume (20 Days) | 49,574 |
Short Selling Information
The latest short interest is 210,641, so 3.00% of the outstanding shares have been sold short.
| Short Interest | 210,641 |
| Short Previous Month | 268,036 |
| Short % of Shares Out | 3.00% |
| Short % of Float | 4.76% |
| Short Ratio (days to cover) | 3.43 |
Income Statement
In the last 12 months, ATRA had revenue of $188.67 million and earned $5.80 million in profits. Earnings per share was $0.56.
| Revenue | 188.67M |
| Gross Profit | 5.54M |
| Operating Income | 19.38M |
| Pretax Income | -233.09M |
| Net Income | 5.80M |
| EBITDA | 23.98M |
| EBIT | 19.38M |
| Earnings Per Share (EPS) | $0.56 |
Full Income StatementBalance Sheet
The company has $22.32 million in cash and $17.67 million in debt, giving a net cash position of $4.66 million or $0.66 per share.
| Cash & Cash Equivalents | 22.32M |
| Total Debt | 17.67M |
| Net Cash | 4.66M |
| Net Cash Per Share | $0.66 |
| Equity (Book Value) | -35.04M |
| Book Value Per Share | -5.02 |
| Working Capital | 10.21M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$63.92 million and capital expenditures -$90,000, giving a free cash flow of -$64.01 million.
| Operating Cash Flow | -63.92M |
| Capital Expenditures | -90,000 |
| Free Cash Flow | -64.01M |
| FCF Per Share | -$9.11 |
Full Cash Flow StatementMargins
Gross margin is 2.94%, with operating and profit margins of 10.27% and 3.07%.
| Gross Margin | 2.94% |
| Operating Margin | 10.27% |
| Pretax Margin | 3.05% |
| Profit Margin | 3.07% |
| EBITDA Margin | 12.71% |
| EBIT Margin | 10.27% |
| FCF Margin | n/a |
Dividends & Yields
ATRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -103.16% |
| Shareholder Yield | -103.16% |
| Earnings Yield | 6.69% |
| FCF Yield | -73.85% |
Analyst Forecast
The average price target for ATRA is $21.00, which is 71.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.00 |
| Price Target Difference | 71.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 7.82% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 20, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jun 20, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
ATRA has an Altman Z-Score of -68.82 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -68.82 |
| Piotroski F-Score | 5 |
